Evidence map›Paper›PMID 28659489›Full record

ArticleJournal of virology2017

Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model.

Juliet Morrison, Abhay P S Rathore, Chinmay K Mantri, Siti A B Aman, Andrew Nishida, Ashley L St John

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Dengue Virus Infection: Immune Response and Therapeutic Targets.The American journal of tropical medicine and hygiene · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Mast Cells Modulate Antigen-Specific CD8Frontiers in immunology · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Juliet MorrisonCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA jmm2105@cumc.columbia.edu ashley.st.john@duke-nus.edu.sg.
Abhay P S RathoreProgram in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore.
Chinmay K MantriProgram in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore.
Siti A B AmanProgram in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore.
Andrew NishidaDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Ashley L St JohnProgram in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore jmm2105@cumc.columbia.edu ashley.st.john@duke-nus.edu.sg.
National University of Singapore · SGColumbia University · USDuke Medical Center · USUniversity of Washington · US

Funding

Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2014 to 2018
$32.6M
NIAID NIH HHS U19 AI109761
6 · The paper itself

Abstract

There are no approved therapeutics for the treatment of dengue disease despite the global prevalence of dengue virus (DENV) and its mosquito vectors. DENV infections can lead to vascular complications, hemorrhage, and shock due to the ability of DENV to infect a variety of immune and nonimmune cell populations. Increasingly, studies have implicated the host response as a major contributor to severe disease. Inflammatory products of various cell types, including responding T cells, mast cells (MCs), and infected monocytes, can contribute to immune pathology. In this study, we show that the host response to DENV infection in immunocompetent mice recapitulates transcriptional changes that have been described in human studies. We found that DENV infection strongly induced metabolic dysregulation, complement signaling, and inflammation. DENV also affected the immune cell content of the spleen and liver, enhancing NK, NKT, and CD8

Indexed as

Gene Expression ProfilingAnimalsAnti-Allergic AgentsDengueDengue VirusDisease Models, AnimalKetotifenMast CellsMiceAnti-Allergic AgentsKetotifendengue feverdengue virusinterferonsmast celltranscriptional regulation

Identifiers

PMID28659489
PMCPMC5571258
OpenAlexW2725371862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.